drugset / Trial / NCT00738959

Safety, Tolerability & PK of AZD0328 in Caucasian & Japanese

NCT00738959 ↗

Phase 1 Completed 64 enrolled AstraZeneca
RandomizedParallel-groupDouble-blind

Summary

This study will be performed to evaluate the safety, tolerability and pharmacokinetics of single and multiple doses of AZD0328 when administered to Japanese and Caucasian healthy male volunteers.

Timeline

Start
2008-06
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD0328 Small molecule — Oral

Indications

No indication recorded.